Benitec Biopharma Inc. Common Stock (BNTC)
Benitec Biopharma Inc. (BNTC) is a biotechnology company focused on developing gene-based therapeutics. It specializes in innovative DNA-based methods, particularly RNA interference (RNAi) technology, to target genetic and viral diseases. The company's approach aims to leverage gene silencing for therapeutic benefits across various medical conditions.
Company News
Benitec Biopharma announced the acceptance of a late-breaking oral abstract for the BB-301 Phase 1b/2a clinical study in Oculopharyngeal Muscular Dystrophy (OPMD) patients. Interim clinical study updates for the first three subjects will be presented at the Muscular Dystrophy Association Clinical and Scientific Conference in March 2025.
Geopolitical tensions in the Middle East, earnings reports from major companies, and the upcoming bitcoin halving event are set to drive market focus this...
Gainers Axcella Health Inc. (NASDAQ: AXLA) shares gained 65% to $0.2887 in pre-market trading after gaining 12% on Monday. The company recently posted a narrower-than-expected quarterly loss. ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares surged 32.9% to $2.10 in pre-market trading. ProMIS Neurosciences announced a $20.4 million private placeme...
A renewed fight against COVID-19 might be coming.
Why day trading penny stocks could be a quick method for profitability The post How Day Trading Penny Stocks Could Make You Money appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.